Download PDF
Thromb Haemost 2015; 113(03): 437-438
DOI: 10.1160/TH14-11-0974
Invited Editorial Focus
Schattauer GmbH

Scoring systems for heparin-induced thrombocytopenia (HIT): Whither now?

Theodore E. Warkentin
1   Department of Pathology and Molecular Medicine, and Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Received: 24 November 2014

Accepted after major revision: 24 January 2014

Publication Date:
29 November 2017 (online)

    Permissions and Reprints

 

Editorial Focus on: Joseph et al. Thromb Haemost 2015; 113: 663-640.

 

  • References

  • 1 Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998; 79: 1-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Warkentin TE, Greinacher A, Gruel Y. et al. Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost 2011; 9: 2498-2500.
    CrossrefPubMedGoogle Scholar
  • 3 Maeda T, Noguchi T, Saito S. et al. Impact of heparin-induced thrombocytopenia on acute coronary artery thrombosis in patients undergoing PCI. Thromb Haemost 2014; 112: 624-626.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Zimrin AB, Warkentin TE. Transient pseudo-thrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism. Thromb Haemost 2013; 109: 971-973.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Ketha S, Smithedajkul P, Vella A. et al. Adrenal haemorrhage due to heparin-induced thrombocytopenia. Thromb Haemost 2013; 109: 669-675.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Greinacher A, Juhl D, Strobel U. et al. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost 2007; 5: 1666-1673.
    CrossrefPubMedGoogle Scholar
  • 7 Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?. Am J Hematol 2007; 82: 1037-1043.
    CrossrefPubMedGoogle Scholar
  • 8 Trehel-Tursis V, Louvain-Quintard V, Zarrouki Y. et al. Clinical and biological features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU. Chest 2012; 142: 837-844.
    CrossrefPubMedGoogle Scholar
  • 9 Tardy-Poncet B, Combe M, Piot M. et al. Effects of argatroban, danaparoid, and fondaparinux on thrombin generation in heparin-induced thrombocytopenia. Thromb Haemost 2013; 109: 504-509.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003; 2: 148-157.
    PubMedGoogle Scholar
  • 11 Lo GK, Juhl D, Warkentin TE. et al. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4: 759-765.
    CrossrefPubMedGoogle Scholar
  • 12 Cuker A, Gimotty PA, Crowther MA. et al. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood 2012; 120: 4160-4167.
    CrossrefPubMedGoogle Scholar
  • 13 Cuker A, Arepally G, Crowther MA. et al. The HIT Expert Probability (HEP) score: a novel pretest probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 2010; 8: 2642-2650.
    CrossrefPubMedGoogle Scholar
  • 14 Joseph L, Gomes MPV, Al Solaiman F. et al. External validation of the HIT Expert Probability (HEP) score. Thromb Haemost 2015; 113: 633-640.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Warkentin TE, Greinacher A. Laboratory testing for heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A. eds. Heparin-Induced Thrombocytopenia. 5th edn.. Boca Raton, FL: CRC Press; 2013. pp. 272-314.
    Google Scholar
  • 16 Pouplard C, Gueret P, Fouassier M. et al. Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2007; 5: 1373-1379.
    CrossrefPubMedGoogle Scholar
  • 17 Linkins LA, Bates SM, Lee AYY. et al. Combination of 4T’s score and rapid gel centrifugation assay excludes HIT in a prospective cohort study. Blood (ASH Annual Meeting Abstracts). 2013 122. Abstract 3535.
    PubMedGoogle Scholar
  • 18 Leroux D, Hezard N, Lebreton A. et al. Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (Stic Expert* HIT) for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 2014; 166: 774-782.
    CrossrefPubMedGoogle Scholar
  • 19 Warkentin TE, Sheppard JI, Moore JC. et al. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoas-says. J Thromb Haemost 2008; 6: 1304-1312.
    CrossrefPubMedGoogle Scholar
  • 20 Raschke RA, Curry SC, Warkentin TE. et al. Improved clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, statum-specific likelihood ratios, and Bayes theorem. Chest 2013; 144: 1269-1275.
    CrossrefPubMedGoogle Scholar